Recent Company News

• 05:04 PM ET Apr 13, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:18 AM ET Apr 16, 2026
  

  StreetAccount Summary - US Pre-market trading update

• 09:17 AM ET Apr 16, 2026
  

  StreetAccount Summary - US Syndicate recap for 16-Apr

• 08:50 AM ET Mar 20, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:51 AM ET Apr 16, 2026
  

  StreetAccount Summary - US Initial Syndicate recap for 16-Apr

• 07:04 AM ET Apr 16, 2026
  

  Adlai Nortye announces $150.0M private placement equity financing ($13.25, 0.00)

• 03:15 PM ET Apr 13, 2026
  

  Street Takeaways - Revolution Medicines Phase 3 RASolute 302 trial of daraxonrasib in previously treated PDAC met all primary and key secondary endpoints ($135.94, +39.51)

• 10:01 AM ET Apr 13, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (115 total)